EP
EXAS

Edgestream Partners’s Exact Sciences EXAS Stock Holding History

Edgestream Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,284
Closed -$891K – 1006
2025
Q3 		$891K Buy
+16,284
New +$814K 0.03% 648
2023
Q4 		– Sell
-31,206
Closed -$2.13M – 897
2023
Q3 		$2.13M Buy
31,206
+16,106
+107% +$1.37M 0.17% 176
2023
Q2 		$1.42M Buy
+15,100
New +$1.18M 0.13% 276
2023
Q1 		– Sell
-17,639
Closed -$873K – 585
2022
Q4 		$873K Buy
+17,639
New +$721K 0.1% 279
2022
Q3 		– Sell
-99,883
Closed -$3.93M – 501
2022
Q2 		$3.93M Buy
99,883
+50,740
+103% +$2.71M 0.31% 101
2022
Q1 		$3.44M Buy
49,143
+29,514
+150% +$2.16M 0.27% 122
2021
Q4 		$1.53M Buy
+19,629
New +$1.73M 0.1% 262
2021
Q3 		– Sell
-37,097
Closed -$4.61M – 524
2021
Q2 		$4.61M Buy
37,097
+5,405
+17% +$645K 0.27% 132
2021
Q1 		$4.18M Buy
+31,692
New +$4.34M 0.23% 165

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Edgestream Partners's EXAS Position: Q4 2025 in Review

Edgestream Partners sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 16,284 shares — an estimated $891K sold.

Edgestream Partners first reported a position in EXAS in Q1 2021 and held it in 9 quarters. The position peaked at $4.61M in Q2 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Edgestream Partners reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Edgestream Partners sold 16,284 Exact Sciences shares in Q4 2025, an estimated $891K.
  • Edgestream Partners first reported a position in Exact Sciences in Q1 2021 and held it in 9 quarters.
  • Edgestream Partners's Exact Sciences position peaked at $4.61M in Q2 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Edgestream Partners's 13F filing for Q4 2025, filed 13 Feb 2026.